Immortal Time and Selection Biases in Study of Direct-Acting Antiviral Treatment and Hepatitis C Outcomes
JAMA Intern Med
.
2023 Jun 1;183(6):624.
doi: 10.1001/jamainternmed.2023.0554.
Authors
Laurent Lam
1
,
Fabrice Carrat
1
Affiliation
1
Sorbonne Université, Institut national de la santé et de la recherche médicale, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
PMID:
37067790
DOI:
10.1001/jamainternmed.2023.0554
No abstract available
Publication types
Comment
MeSH terms
Antiviral Agents / therapeutic use
Hepacivirus / genetics
Hepatitis C* / drug therapy
Hepatitis C, Chronic* / drug therapy
Humans
Selection Bias
Substances
Antiviral Agents